The FSWPG delegation, led by senior mining and energy executives, met with Tanzanian government representatives, local partners, mining stakeholders and workers during its latest visit to the country. The meetings are part of FSWPG’s broader strategy to establish long-term partnerships supporting Tanzania’s natural-resource development while creating investment, employment and infrastructure opportunities. 

$25 Million Capital Raise — Investor Call to Action

FSWPG is inviting qualified institutional investors, strategic investors, family offices, mining and energy companies, infrastructure funds and other long-term capital partners to participate in its targeted $25 million initial capital raise. The capital will support the advancement of FSWPG’s Tanzania strategic mineral portfolio, including gold, rare earth elements, cobalt, tantalite and lithium, as well as project development, technical evaluation, mining operations, infrastructure and processing initiatives.

Investors and strategic partners interested in participating in Tanzania’s growing critical-minerals and natural-resources sector are encouraged to contact FSWPG to discuss investment opportunities, strategic partnerships and project-level participation. FSWPG welcomes qualified parties seeking exposure to long-term resource development and value-added opportunities in Tanzania and the broader East African market. Please contact our Team at https://www.falconeswp.com/blank-2

The initial capital is intended to establish the foundation for FSWPG’s broader Tanzania investment platform and accelerate the development of qualified projects through rigorous technical, financial, regulatory and commercial due diligence. The capital will also support the advancement of strategic partnerships and position qualifying projects for larger-scale institutional and project financing.

 Tanzania Strategic Mineral Portfolio:

• Gold: 36,600 kg
• Rare Earth Elements: 1.2 million metric tons (MT)
• Cobalt: 25,000 MT
• Tantalite: 20,000 MT
• Lithium: 20,000 kg

This data comes from the Tanzanian Government Ministry of Minerals Survey.

Supporting Tanzania’s Economic and Energy Resilience

FSWPG’s strategy is designed to align international private capital with Tanzania’s national development priorities. The company intends to work with Tanzanian stakeholders to advance responsible mineral development, strengthen domestic and international supply chains, support energy resilience and attract additional institutional and strategic investment.

The company believes Tanzania has the potential to become an increasingly important regional platform for critical minerals, energy development and industrial investment in East Africa.

“Tanzania represents an important strategic opportunity for long-term investment, economic development and partnership,” said Hussein Kandoro, CEO of Falcone Tanzania Mining Holding Ltd. “Our objective is not simply to develop mineral assets. We want to build sustainable partnerships that create jobs, strengthen local capabilities, attract international capital and contribute meaningfully to Tanzania’s economic and energy resilience.”

Building Long-Term Strategic Partnerships

FSWPG is also evaluating opportunities to develop downstream processing and value-added capabilities that could allow Tanzania to capture a greater portion of the economic value generated by its natural resources.

The company’s broader international strategy includes potential cooperation with investors and industrial partners from the United States, Asia and the Middle East, creating opportunities for technology transfer, financing, processing, infrastructure development and international market access.

“We are calling on serious investors, strategic partners and international institutions to engage with us,” said Michael Falcone, Chairman of Falcone Sovereign Wealth Partnership Group. “Our vision is to build partnerships that go beyond extracting resources. We want to help develop productive assets, infrastructure, energy capacity and industrial value chains that can generate lasting economic benefits for Tanzania and its people.”

FSWPG emphasized that all investment opportunities remain subject to appropriate legal, regulatory, technical, environmental, financial and commercial due diligence.

About Falcone Sovereign Wealth Partnership Group

Falcone Sovereign Wealth Partnership Group Inc. (FSWPG) is an international investment and strategic partnership organization focused on natural resources, energy, infrastructure, technology and economic-development opportunities.

Through its investment platforms and operating partners, FSWPG seeks to connect institutional and strategic capital with projects capable of supporting long-term economic growth, resource security, infrastructure development and international investment partnerships.

www.falconeswp.com

SOURCE Falcone Sovereign Wealth Partnership Group Inc.

Leading mechanical contractor with 60-year history joins Optimum Energy platform

BATON ROUGE, La., Aug. 12, 2026 — Optimum Energy Co., a Bernhard Capital Partners (“Bernhard”) portfolio company and global holistic infrastructure solutions provider, today announced the acquisition of Hussung Mechanical Contractors and HMC Service Company, a full-service mechanical infrastructure services firm for healthcare systems, universities, manufacturers, and mission-critical facilities for over 60 years.

The acquisition combines two highly complementary organizations with deep expertise serving complex, mission-critical facilities. Through Hussung’s mechanical contracting and field service capabilities and Optimum Energy’s engineering, central utility infrastructure, operations, and performance optimization expertise, the platform is positioned to deliver more comprehensive infrastructure solutions while strengthening its presence in attractive end markets.

“Hussung has built exactly the kind of organization we want to grow alongside,” said Lisa Roy, CEO and President at Optimum Energy. “Their technical depth, their culture of accountability, and the reputation they have earned over 60 years are real and rare. We are adding a team that makes the entire platform stronger.”

“This acquisition reflects the strategy behind how we build platforms,” said Jonathan de Lauréal, Managing Director at Bernhard. “We identify and bring together market-leading businesses whose expertise, customer relationships, and technical capabilities create end-to-end offerings with greater scale and reach. Optimum Energy and Hussung are a strong example of this strategy. Together, they form a more complete infrastructure platform that can serve customers across the full facility lifecycle while expanding service capabilities and creating a foundation for long-term growth.”

Optimum Energy is a global leader in holistic infrastructure solutions, delivering integrated services across the full facility lifecycle for mission-critical facilities. From engineering, design, and construction through central utility plant development, ongoing operations and maintenance, and long-term performance optimization, Optimum Energy serves healthcare systems, universities, and manufacturers at scale. Its proprietary AI technology draws on 20 years of central plant performance data, and its dedicated Remote Services team monitors and optimizes facility systems continuously across its global portfolio.

The addition of HMC’s mechanical contracting and field service expertise expands Optimum Energy’s in-house execution capability and strengthens its ability to self-perform across every phase of the infrastructure lifecycle. For customers seeking access to this full platform without upfront capital, Optimum Energy’s Energy-as-a-Service model provides flexible, off-balance sheet financing structures.

“My grandfather and his brother started this company with a straightforward promise: do quality work, act with integrity, and take care of the customer,” said David C. Hussung, CEO of Hussung Mechanical Contractors/HMC Service Company. “Six decades later, that promise is still the reason customers call us and the reason people build careers here. This partnership gives HMC the platform to grow faster and smarter without changing the foundation that made this company worth building in the first place.”

Stephens Inc. served as financial advisor and Calfee, Halter & Griswold LLP served as legal counsel to Hussung Mechanical Contractors and HMC Service Company. Fishman Haygood LLP served as legal counsel to Optimum Energy and Bernhard. 

About Bernhard Capital Partners

Bernhard Capital Partners is a private markets investment firm focused on building market-leading infrastructure services and asset platforms across essential sectors. With more than $6 billion in assets under management, the firm invests in complex, expansive and often regulated markets characterized by durable demand. Bernhard applies a disciplined, thematic investment strategy, paired with deep sector expertise and operational experience, to enhance performance, scale platforms and support long-term growth. Bernhard’s specialized approach is designed to perform across market cycles, delivering consistent outcomes for investors, partners and communities served across the portfolio. For more information, visit bernhardcapital.com.

About Optimum Energy Co.

Optimum Energy Co. is a global holistic infrastructure solutions company serving mission-critical facilities across healthcare, higher education, and advanced manufacturing. The company delivers integrated infrastructure services spanning the full facility lifecycle: engineering, design, construction, central utility plant development and modernization, mechanical and energy systems, ongoing O&M and asset management, and mechanical contracting and field services through HMC. Built on 20 years of central plant performance data, proprietary AI technology, and a dedicated Remote Services team that monitors and optimizes facility systems continuously across its global portfolio, Optimum Energy delivers sustained performance improvements that no traditional O&M provider can match. Its Energy-as-a-Service (EaaS) model enables clients to access this full platform through flexible, off-balance sheet financing structures, accelerating cost savings and performance goals without upfront capital commitment. For more information, visit www.optimumenergyco.com.

About Hussung Mechanical Contractors and HMC Service Company

Hussung Mechanical Contractors / HMC Service Company is a 4th generation family-owned and operated mechanical contractor and service company specializing in the design, installation, and service of HVAC, plumbing, medical gas, and piping systems for healthcare, higher education, manufacturing, and mission-critical facilities, as well as other commercial and industrial sectors. The companies have been serving these industries in Kentucky and Indiana since 1966, delivering high-quality and innovative solutions for complex and challenging projects. Its objectives are to build long-term relationships with their clients, based on trust, respect, and collaboration. There is a commitment to providing the best value for clients, by delivering projects on time, on budget, and with the highest standards of quality and safety.

Media Contacts

Prosek Partners for Bernhard Capital Partners
[email protected]

SOURCE Bernhard Capital Partners Management, LP

RICHMOND, Va., Aug. 12, 2026 — The Virginia Retirement System’s trust fund grew to $135.2 billion in market value as of June 30, 2026, following a 12.1% investment return, net of fees, for the fiscal year. The return exceeded the fund’s long-term assumed rate of return of 6.75%.

This year’s return continues to build on a decade of growth, with the fund’s market value increasing by approximately 10.1% over the last year.

The fund’s total performance met or exceeded board-established custom benchmarks over the five and 10-year periods and was just short of the benchmarks for the one- and three-year periods. However, the three- five- and 10-year returns exceeded VRS’ actuarial assumed rate of return. Investment earnings remain the largest source of retirement benefit funding, supporting approximately two-thirds of benefit payments.

“Managing a retirement trust fund requires a long-term commitment to responsible stewardship,” said Susan T. Gooden, Ph.D., chair of the VRS Board of Trustees. “Over the years, VRS has benefited from an experienced investment team that carefully manages the fund while remaining focused on its responsibility to members and retirees.”

In the past decade, VRS’ investment team has generated an additional $6 billion compared with a passive, indexed investment approach, Dr. Gooden said. “That added value strengthens the trust fund and helps maximize every dollar entrusted to us.”

Andrew Junkin, VRS’ chief investment officer, said this year’s results reflect an investment strategy rooted in diversification with a disciplined approach to risk management.

“Results are built over years, not quarters,” Junkin said. “Our team stays focused on the long term, balancing risk and opportunity as markets change. By combining broad diversification with active decision-making, we’ve added value across market cycles while positioning the fund to meet its obligations for decades to come.”

FY 2026 Performance by Asset Class

Major asset classes within VRS’ portfolio performed as follows:

• Public equity program returned 23.8%
• Private equity program returned 5.2%
• Real assets program returned 6.7%
• Credit strategies program returned 8.3%
• Diversifying strategies returned 7.1%
• Private investment partnerships returned 9.7%
• Fixed income program returned 5.3%

Watch VRS CIO Andrew Junkin break down this year’s return.

For more information about VRS’ investment strategy, visit varetire.org/investments.

About VRS

The Virginia Retirement System, an independent state agency based in Richmond, delivers retirement and other benefits to covered Virginia public sector employees. VRS ranks as the 15th largest public or private pension fund in the U.S. and the 36th largest in the world, serving more than 861,000 active and inactive members, retirees and beneficiaries. Members include public school teachers, political subdivision employees (cities, towns, special authorities and commissions), state agency employees, public college and university personnel, state police, Virginia law officers and the judiciary. Approximately 864 employers participate in VRS.

SOURCE Virginia Retirement System

DUBAI, UAE, Aug. 12, 2026 — A cross border team from global law firm Greenberg Traurig represented Moove, the global mobility company building the operating layer for autonomous mobility, on its US$250 million Series C funding round.

The financing round was led by Mubadala Investment Company and co-led by Woven Capital, Toyota’s Growth Fund, and Ion Pacific, valuing Moove at US$2.1 billion. The round also included participation from BlueCrest Capital Management, Sona Capital, and The Raptor Group, alongside existing investors including BlackRock, MUFG, Franklin Templeton, Uber, Left Lane, Square Associates, The Latest Ventures, and the Ontario Power Generation Pension Plan. The transaction marks a significant milestone in Moove’s growth and further strengthens its position as a leading global infrastructure platform for autonomous mobility.

The funding will support the expansion of Moove’s autonomous vehicle business, including autonomous fleet ownership and robotics-first depot infrastructure, as well as future growth initiatives and new market launches globally.

Moove is a global mobility company building the operating layer for autonomous mobility. The company finances, owns, and operates productive mobility assets for leading mobility platforms across manned and autonomous transportation. Moove operates across 13 countries and 29 cities, with approximately 42,000 vehicles and more than 3,300 employees worldwide.

The team from Greenberg Traurig’s Dubai office was led by Head of the UAE Corporate Practice Shareholder Chadi Salloum and Corporate Shareholder Krishen Patel and by Corporate Shareholder Cees v. Oevelen from Greenberg Traurig’s Amsterdam office. The team was supported by Senior Associate Maquina Lame, and Associates Abdulla Al Hashili, Justin Hool and Gabe Wijnja.

“From the outset, the GT team understood both the legal complexity and the commercial priorities of the transaction. They managed a challenging multi-jurisdictional process involving numerous counterparties with professionalism and efficiency. We valued having advisers who were not only technically capable, but who were commercially driven and were genuinely invested in getting the deal over the line. Their support was instrumental in helping us complete the most significant financing in Moove’s journey to date,” said Stavros Panayi, chief legal officer, Moove.

Greenberg Traurig launched in the Middle East in 2023 with offices in Riyadh, Dubai and Abu Dhabi. The firm has been growing steadily in the region, and planting key roots in the industries and business sectors most active in the Middle East, including real estate, infrastructure and transportation, energy and natural resources, hospitality, finance and restructuring, mergers and acquisitions, private equity, private credit, sports and entertainment — including venue, talent, entertainment, licensing, and other needs — capital markets, and arbitrations and disputes.

Greenberg Traurig’s Riyadh office is operated by Greenberg Traurig through Greenberg Traurig Khalid Al-Thebity Law Firm. Greenberg Traurig’s Dubai office is operated by Greenberg Traurig Limited. Greenberg Traurig’s Abu Dhabi office is a branch of Greenberg Traurig, P.A.

About Greenberg Traurig: Greenberg Traurig, LLP has approximately 3,000 attorneys across 51 locations in the United States, Europe, the Middle East, Latin America, and Asia. The firm’s broad geographic and practice range enables the delivery of innovative and strategic legal services across borders and industries. Recognized as a 2025 BTI “Best of the Best Recommended Law Firm” by general counsel for trust and relationship management, Greenberg Traurig is consistently ranked among the top firms on the Am Law Global 100, NLJ 500, and Law360 400. Greenberg Traurig is also known for its philanthropic giving, culture, innovation, and pro bono work. Web: www.gtlaw.com.

SOURCE Greenberg Traurig, LLP

More than 750 backers support DESLOC’s low-light self-charging solar smart lock, making it the highest-funded smart lock project on Kickstarter since 2023 based on publicly available campaign data

SAN FRANCISCO, Aug. 12, 2026 — DESLOC, a global smart lock brand, announced that its V150 Plus self-charging solar smart lock has completed its Kickstarter campaign, raising more than $500,000 from 755 backers.

The campaign reached its initial funding goal within one hour and surpassed $100,000 within 12 hours. By the end of the campaign, the V150 Plus had raised more than 50 times its original funding goal.

The milestone also reflects a growing shift in homeowner priorities. As smart locks add more features, battery life and charging frequency are becoming increasingly important considerations. More homeowners are looking for worry-free smart lock experiences with less charging hassle and less day-to-day maintenance, the exact pain point the V150 Plus was designed to address.

More Than $500,000 Raised for a More Worry-Free Smart Lock Experience

Smart locks today offer more features than ever, from facial and fingerprint recognition to remote access and app control. But these added capabilities also increase power consumption.

For homeowners, battery life is more than a technical specification. A smart lock is something they rely on every day, and frequent charging or battery replacement can quickly become an inconvenience.

DESLOC developed the V150 Plus around that everyday concern.

The lock combines a perovskite low-light energy-harvesting panel, a 10,000mAh battery and an intelligent power management system. Together, these technologies allow the lock to collect energy from ambient light and use it to help support everyday operation.

The V150 Plus also features 3D facial recognition, curved fingerprint recognition, built-in Wi-Fi, door-status detection and app-based remote management. The goal is to provide convenient keyless access while reducing the amount of attention users need to give to battery maintenance.

Built for Long Endurance, Verified by TÜV Rheinland

The V150 Plus has also received TÜV Rheinland Long-Endurance Certification, providing independent third-party validation of its energy management and long-endurance capabilities.

The certification was conducted in accordance with TÜV Rheinland’s 2 PfG 3330 specification.

Rather than simply testing whether the solar panel can generate electricity, the certification looks at a more practical question: Can the energy collected from ambient light meaningfully support the lock’s everyday operation?

TÜV Rheinland evaluated the V150 Plus across a range of functions, including standby power consumption, facial recognition, fingerprint recognition, remote control and daily unlocking.

Under the specified test conditions, including challenging low-light environments, the V150 Plus was able to continuously harvest ambient light and replenish its battery, helping maintain a balance between energy generation and everyday power consumption.

For consumers, the benefit is straightforward: the solar panel is not simply an added feature. It is designed to contribute meaningful power to the lock’s daily operation, helping reduce manual charging and ease the battery anxiety often associated with feature-rich smart locks.

TÜV Rheinland also evaluated environmental factors relevant to real-world front-door use, including dust and water protection, temperature and humidity changes, temperature cycling, and indoor-outdoor temperature differences.

Market Demand Meets Independent Technical Validation

The Kickstarter campaign reflects strong consumer demand for the V150 Plus, while TÜV Rheinland’s certification provides independent technical validation of its long-endurance performance.

The V150 Plus campaign suggests that meaningful smart lock innovation does not always mean adding more features. It can also mean making the technology people already use more reliable, longer-lasting and easier to live with.

More than $500,000 in crowdfunding represents strong consumer support for that direction. TÜV Rheinland’s certification adds an independent technical assessment of the V150 Plus’ long-endurance capabilities.

Together, the two milestones reinforce DESLOC’s focus on solving practical user needs and creating smart home products that require less day-to-day maintenance.

The DESLOC V150 Plus is moving toward its next stage of availability, and pre-orders for the DESLOC V150 Plus are now live.

For product updates, availability and pre-order details, visit desloc.com.

About DESLOC

DESLOC is a global smart lock brand focused on making trusted home security simpler, smarter, and more accessible. Backed by parent company DESMAN, one of Asia’s leading smart lock manufacturers with 17 years of industry experience and nearly 10 million family users worldwide, DESLOC combines proven biometric technologies, advanced security algorithms, and rigorous product testing to deliver reliable smart access solutions for modern homes.

With more than 400 industry patents, DESLOC develops smart locks designed for everyday families, homeowners, and smart home users who want strong security, keyless convenience, and long-lasting performance in an easy-to-use package.

SOURCE DESLOC

Experienced digital health executive Kelly Benning joins as CEO and Co-Founder

INDIANAPOLIS, Aug. 12, 2026 — Suvi Health announced today the launch of their Ambient AI Care Coordination Platform to bring clarity, compassion and continuity to patients’ hospital stays. The company was created by the 1842 Fund by Alloy Partners, and is presently in active collaboration with Mayo Clinic and the University of Notre Dame.

As hospitals nationwide face sustained pressure from staffing shortages, delayed discharges and increasing patient demand, Suvi Health aims to improve care delivery at critical transition points in the patient journey. Suvi Health’s ambient AI is designed to capture context, reduce friction and translate complex medical conversations into shared understanding.

By supporting recovery and discharge at the bedside and beyond, Suvi Health was founded to help care teams focus on what they do best: caring for people, not documentation, while ensuring patients and families feel heard, informed and supported during one of life’s most vulnerable experiences. Artificial intelligence is intended to augment and support clinical decision-making, not replace the expertise, judgment, and accountability of healthcare professionals.

“At its core, Suvi Health’s core principles are about fostering trust and  understanding at moments when they matter most,” said Kelly Benning, CEO and co-founder of Suvi Health. “When healthcare teams are stretched thin and families are overwhelmed, we believe technology should step in, quietly, to listen, support and help everyone move forward together toward healing and home.”

“Healthcare doesn’t need more technology competing for clinicians’ attention, it needs systems that quietly remove friction and help people stay connected during some of the most complex moments of care,” said Shawn Albert, CTO and co-founder. “We built Suvi Health’s ambient AI platform to work quietly in the background so care teams can focus less on coordination and more on patients and families.”

Suvi Health was launched by the 1842 Fund and Alloy Partners, collaborating with Mayo Clinic on co-development, design collaboration and as a first pilot site. Collaboration with researchers from Notre Dame and clinicians from Mayo Clinic Florida provided Suvi Health with the clinical insight and foundational research applied toward tackling complex healthcare delivery and AI challenges.

“At Notre Dame, our mission calls us to find solutions that support the most vulnerable, and that includes the upholding of human dignity in our healthcare system,” said Jeffrey F. Rhoads, the John and Catherine Martin Family Vice President for Research and professor of aerospace and mechanical engineering at Notre Dame. “This partnership between Suvi Health and the 1842 Fund offers a powerful tool for facilitating effective, patient-centered care, one that turns bedside conversations into a clear plan patients and families can actually understand and act on.”

“Suvi is a great example of the opportunities we seek to address through our unique ‘research co-creation’ approach,” said Mike Joslin, partner at the 1842 Fund. “Efforts like these are built around combining academic research, clinical expertise from the industry and our venture studio playbook to drive real-world impact.”

To learn more about Suvi Health, visit suvi.health.

About Suvi Health
Suvi Health is an Ambient AI Care Coordination Platform to bring clarity, compassion and continuity to patients’ hospital stays. Suvi Health’s platform creates a trusted, secure layer of support that listens with empathy to conversations between patients, families and the entire care team. Working invisibly in the background, Suvi Health bridges the gap between complex medical discussions and true understanding by aligning nurses, physicians and caregivers. Suvi Health was built by 1842 Fund and Alloy Partners in collaboration with Mayo Clinic and the University of Notre Dame. For more information, visit suvi.health.

About the 1842 Fund
The 1842 Fund invests in mission-driven, advantaged startups aligned to the strategic framework of the University of Notre Dame. In addition to investing in faculty, researcher and student startups emerging from campus, the 1842 Fund funds new startups launched from the 1842 Studio, a venture studio that co-creates de novo startups alongside university researchers and industry partners. The 1842 Fund and Studio are managed by Alloy Partners and focus on building and funding ventures that address important societal challenges tied to the mission of the University of Notre Dame. For more information, visit www.1842fund.com.

About Alloy Partners
Alloy Partners is a venture builder that co-creates advantaged startups and venture studios with corporations. Alloy Partners works with partners through their journey from defining a venture strategy to systematically conceiving, launching, investing in and scaling a portfolio of venture-backed startups. Founded in 2020 and headquartered in Indianapolis, the Alloy Partners portfolio includes over 40 companies and seven venture studios started in partnership with leading organizations, including Elanco, Huntington Bank, Eli Lilly, Capital One, Catalyst by Wellstar, Warner Bros. Discovery, University of Notre Dame and more. For more information, visit www.AlloyPartners.com.

About the University of Notre Dame
The University of Notre Dame is the leading global Catholic research university, providing a distinctive voice in higher education. Rigorously intellectual, boldly moral in orientation and firmly embracing a service ethos, Notre Dame is rated among the top institutions of higher learning in the United States and is a member of the Association of American Universities. Founded in 1842 and located adjacent to South Bend, Indiana, the University advances human understanding through research, scholarship, education and creative endeavor to be a powerful force for good in the world. For more information, visit nd.edu.

Mayo Clinic has a financial interest in the technology referenced in this press release. Mayo Clinic will use any revenue it receives to support its not-for-profit mission in patient care, education and research.

Media Contact:
Jen Carroll
PANBlast for Alloy Partners
[email protected]

Erin Fennessy
Notre Dame Research
[email protected] 

SOURCE Alloy Partners

Oversubscribed round with proceeds to support continued clinical development

SAN DIEGO, Aug. 12, 2026 — Amplifica Holdings Group, Inc. (“Amplifica”), a privately held, clinical-stage biopharmaceutical company developing novel therapies for hair growth, today announced the closing of an oversubscribed $26 million Series B Preferred Stock financing. The financing was led by Tasso Partners, LLC, with participation from Eli Lilly and Company, principals of Scopia Capital Management, LP, and other new and existing investors. Proceeds will be used to advance clinical development of the Company’s novel pipeline candidates, which are designed to reactivate dormant hair follicles and promote the growth of new hair. Currently marketed products are primarily intended to slow or prevent further hair loss.

“Closing this oversubscribed round reflects strong investor conviction in the science behind our injectable approach and in the size of the opportunity it addresses,” remarked Frank Fazio, President and CEO. “This capital allows us to accelerate our mission to deliver next-generation products to patients confronting the physical and emotional challenges of hair loss.”

Androgenetic alopecia is estimated to affect more than 50 million men and 30 million women in the United States. Existing daily-use treatments such as finasteride and minoxidil, though considered the standard of care, have delivered only modest improvements in hair count, and their daily-use profile introduces challenges including poor patient compliance, tolerability and side-effect concerns, and limited efficacy and applicability in women. These ongoing limitations have hindered broader adoption and further underscore the need for innovation in this space.

“Amplifica has built a proprietary portfolio of signaling molecules that regulate the hair follicle growth cycle, and this financing advances them further into clinical development,” said Wajdie Ahmad, Co-Founder and Executive Chairman. “Our discovery platform has yielded candidates that activate follicle regeneration through distinct, complementary mechanisms of action. Advancing multiple mechanisms in parallel maximizes our probability of clinical success and reinforces our leadership in hair regeneration for men and women.”

With this financing, the Company embarks on its next growth phase, focusing its attention on clinical development activities within its injectable product pipeline.

About Amplifica Holdings Group, Inc.

Amplifica is a clinical-stage biopharmaceutical company focused on developing novel treatments to address androgenetic alopecia (hair loss), a condition estimated to affect over 50 million men and over 30 million women in the United States alone. The Company is taking a nature-inspired scientific approach using a molecular mechanism that regrows natural hair. The Company has identified and isolated unique signaling molecules that stimulate hair follicles to regrow hair. Amplifica will be initiating product development programs and clinical trials to evaluate the safety and efficacy of its core technology, as well as obtain all applicable regulatory approvals.

For more information, please visit https://amplificabio.com.

Forward-Looking Statements

This press release contains “forward-looking statements” within the meaning of the “safe harbor” provisions of the Private Securities Litigation Reform Act of 1995. Forward-looking statements may be identified by the use of words such as “anticipate,” “believe,” “contemplate,” “could,” “estimate,” “expect,” “intend,” “seek,” “may,” “might,” “plan,” “potential,” “predict,” “project,” “target,” “aim,” “should,” “will,” “would,” or the negative of these words or other similar expressions. These forward-looking statements are based on the Company’s current beliefs and expectations. Forward-looking statements include, but are not limited to, statements regarding the potential efficacy of the Company’s product candidates, the Company’s expectations with respect to development and commercialization of the Company’s product candidates, the initiation or completion of any future clinical trials. Actual results may differ from the forward-looking statements expressed by the Company in this press release, and consequently, you should not rely on these forward-looking statements as predictions of future events. Forward-looking statements contained in this announcement are made as of this date, and the Company undertakes no duty to update such information except as required under applicable law.

Contact(s)

Company
[email protected]

Media
EvolveMKD – [email protected]

SOURCE Amplifica Holdings Group, Inc.

Funding brings total capital raised to $62 million as the Company expands pharmaceutical co-development partnerships and accelerates the Hybrid Drug category

NEW YORK, Aug. 12, 2026 — Remepy, the pioneer of Hybrid Drugs, today announced the closing of a $36 million Series A financing round led by O.G. Venture Partners and M Ventures, the corporate strategic venture arm of Merck KGaA, Darmstadt, Germany, with participation of existing and new investors including NFX, Vine Ventures, Qumra Capital, TechAviv, 97212 Ventures, Fresh Fund, PsyMed Ventures, Tadmor Group, Key1 Capital, and IT-Farm Corp.

The proceeds will accelerate the Company’s pharmaceutical co-development partnerships and the expansion of its Hybrid Drug pipeline and platform, as well as fund the global Phase III clinical development of Hybridopa, Remepy’s lead program for Parkinson’s disease that will commence in Q4 2026. This funding brings the total capital raised by the Company to $62 million.

Remepy partners with leading pharmaceutical companies to develop Hybrid Drugs, a new class of drugs that combine prescription medicines with personalized, AI-driven therapeutic apps. Hybrid Drugs integrate pharmacology with adaptive physical, cognitive, and behavioral interventions into a single treatment, enabling scalable, multidisciplinary care through the standard prescription model. Beyond improving patient outcomes, the platform creates significant strategic value for pharmaceutical companies by generating new intellectual property, enabling lifecycle management, differentiating existing and future drugs, and potentially increasing clinical trial success through personalized integrative treatment.

Supported by emerging FDA frameworks for drug-software combination products and regulatory alignment, the Hybrid Drug model is rapidly gaining industry momentum. The Company recently announced a strategic collaboration with Merck KGaA, Darmstadt, Germany, to develop Hybrid Drugs across multiple indications, beginning with rare tumors.

Hybridopa, Remepy’s Hybrid Drug program for Parkinson’s disease, has generated encouraging Phase IIa clinical results demonstrating improvements in both motor and non-motor symptoms, supported by peer-reviewed publications[i][ii] highlighting the biological mechanisms underlying the Hybrid Drug clinical effect. The Company is now preparing the program for global Phase III development, expected to commence in Q4, 2026. Hybridopa is an investigational product and has not yet been approved by the FDA.

Michal Tsur, PhD, and Or Shoval, Co-CEOs of Remepy, “We believe medicine is entering a new era, where every breakthrough drug will be paired with personalized intelligence to maximize its impact for every patient. Over the past year, we’ve demonstrated that this vision is achievable through clinical validation, peer-reviewed science, regulatory alignment, and partnerships with leading pharmaceutical companies. This financing allows us to advance Phase III of Hybridopa for Parkinson’s disease, and expand the Hybrid Drug model across multiple therapeutic areas.”

Ziv Kop, Managing Partner at O.G. Venture Partners (Israel), “We’re excited to lead Remepy’s Series A and support an exceptional team pioneering a new category of medicine. By bringing together biotechnology, AI, and digital health, Remepy is redefining how medicines are developed and delivered. With compelling clinical data, growing regulatory momentum, and strong validation from leading pharmaceutical partners, we believe Hybrid Drugs have the potential to transform patient care – and we’re proud to support Remepy in its next phase of growth.”

Dr. Eyal Ben Ami, Scientific Lead at M Ventures, “Remepy’s pioneering Hybrid Drugs approach reflects the growing importance and applicability of integrating AI into the delivery of health and physical medicines. Our investment from M Ventures is intended to further enable the company, underscoring our belief that this new class of medicine – that combines innovative therapeutics with AI-driven, patient-centered care – has the potential to redefine medicine. We look forward to advancing it across multiple drug classes and disease areas.”

Gigi Levi-Weiss, founding partner at NFX, “We’ve believed in Remepy’s vision since day one. The team’s ability to translate bold ideas into clinical and commercial momentum has only strengthened our conviction, and we’re excited to continue supporting the company as it enters its next stage of growth.”

About Remepy

Remepy is pioneering Hybrid Drugs, a new class of drugs combining traditional drugs with personalized, AI-driven therapeutic apps. Remepy partners with leading pharma companies to bring to market Hybrid Drugs, that integrate pharmacology with adaptive physical, cognitive, and behavioral interventions into a single treatment, enabling scalable, multidisciplinary care within a standard drug prescription model. Supported by emerging FDA frameworks for drug–software combination products and strong clinical data, this model is rapidly gaining traction. Remepy’s lead program, Hybridopa for Parkinson’s, is entering Phase III following strong Phase IIa results. Remepy is turning drugs into intelligent, software-enabled, adaptive treatment platforms. For additional information, please visit: https://www.remepy.com/   

About O.G. Venture Partners O.G. Venture Partners (OGVP) is a global, single-LP venture capital fund founded in 2017 and backed by Eyal Ofer’s Ofer Global, and focused primarily on early growth-stage investments, typically in Series B and C rounds. OGVP manages over $1.5 billion in assets under management (AUM). Its active portfolio includes companies such as Lendbuzz, Coralogix, Via, Neko Health, Connecteam, Peregrine, Superplay, and Buildots, among others.

About M Ventures
M Ventures is the strategic, corporate venture capital arm of Merck KGaA, Darmstadt, Germany. From its headquarters in the Netherlands and offices in Germany, USA and Israel, M Ventures invests globally in transformational ideas driven by innovative entrepreneurs. Taking an active role in its portfolio companies, M Ventures teams up with management teams and co-investors to translate scientific discoveries into commercial success. M Ventures focuses on identifying and financing novel solutions to some of the most difficult challenges, through company creation and equity investments in fields that will impact the vitality and sustainability of Merck KGaA, Darmstadt, Germany’s current and future businesses.

http://www.m-ventures.com/

About NFX

NFX invests in seed and pre-seed founders building the next generation of category-defining companies. Our five General Partners have founded ten companies with more than $10 billion in combined exits. Since launching in 2017, we’ve backed 25 unicorns across San Francisco, Silicon Valley, and Israel. NFX manages $1.5B in assets, and we are actively investing out of our fourth fund.

Media contact:

Tsipi Haitovsky
Global Media Liaison
Remepy
[email protected] 

(1)  ^[i]Catalogna et al., 2026, Brain Communications

(2)  ^[ii] Catalogna et al., 2026, npj Parkinson’s

SOURCE Remepy

Trusted by a quarter of the Fortune 50, Skan AI delivers sustainable, reliable, and measurable AI outcomes across the most complex, regulated workflows in banking, insurance, and healthcare

MENLO PARK, Calif., Aug. 12, 2026 — Skan AI, the context graph of work for enterprise AI, today announced $63 million in funding co-led by Cathay Innovation and Dell Technologies Capital, with participation from Citi Ventures, Bloomberg Beta, State Farm Ventures®, and Wipro Ventures. The funding comes alongside the launch of Skan AI’s enterprise AI platform including the general availability of Skan AI Blueprint and Skan AI Agents. Together with Skan AI Intelligence, these products provide enterprises with a complete platform for deploying AI grounded in true context from how a business actually runs.

“Everyone is obsessed with building a better car. We think the bigger opportunity is building a better navigation system,” said Avinash Misra, Co-founder and CEO, Skan AI.

Enterprises have adopted agentic AI fast, but few are turning it into scalable value: Gartner finds only eight percent have agents in production, and 95 percent of early implementations will require a complete redesign. Both stats point to the same gap, and it isn’t simply that agents lack context. Every company filling agents with documentation and logs is discovering the same thing: the source data was never the whole truth. Skan AI fixes the source data problem at the source: delivering more than $500 million in measured uplift by grounding agents in how work actually gets done.

“Enterprise work context is becoming the foundational infrastructure layer for enterprise AI, the same way CRM became the system of record for customer relationships. Skan AI is the only company we have seen that builds that context from direct observation of work itself and carries it all the way through to agents running in production. With a fourth of the Fortune 50 already running on Skan AI, we believe this is one of the defining platform companies of the next decade,” said Simon Wu, Partner, Cathay Innovation.

The funding follows a breakout year, with Skan AI growing more than 300 percent year over year and average net dollar retention of 150 percent as customers expand across the enterprise. The company recently surpassed 25 billion work signals processed, now works with seven of the ten largest US banks, and partnered with the University of Missouri to establish a new research frontier at the intersection of AI, enterprise systems, and human work.

Skan AI, powered by NVIDIA AI Enterprise and NVIDIA NIM microservices, delivers sustainable, reliable, and measurable AI outcomes through a platform built for the complexity of real enterprise work. Its three products work as a continuous cycle, each one feeding the next:

• Skan AI Blueprint: Discovers and prioritizes AI opportunities across every system people use, including the legacy environments and regulated workflows most tools can’t reach.
• Skan AI Intelligence: Gives leaders everything they need to manage workflows at scale: process benchmarking, workforce management, and identification of technology and automation opportunities.
• Skan AI Agents: Executes autonomously against the customer’s work context, built from thousands of observed real cases, tested against reality before deployment, continuously updated as the business evolves, with human oversight and full auditability at every step.

These products are already in production at some of the world’s largest enterprises. At a top U.S. bank, Skan AI observed 11.2 million context switches and multiple variations across 1,500 finance professionals, uncovered $37 million in operational friction. The company turned those observations into context that agents could execute against, reducing cost per transaction by 32 percent, increasing throughput by 41 percent, and delivering $18 million in annualized savings. What began as 11.2 million observations of human work became the context for AI to perform that work.

“A financial institution’s real differentiation isn’t its products — it’s the decades of experience and operational know-how that shape how things get done internally. With NVIDIA platform, Skan AI observes thousands of real cases to capture how the enterprise’s best performers operate, then turns that into agents that run the work their way, all while running on infrastructure the financial institution owns and controls to be governed and auditable at every step,” said Aser Blanco, Global Head of Banking, NVIDIA.

“Skan AI has been an important partner helping us better understand how work actually happens across our operations,” said Cijo Joseph, Mitie Chief Technology & Digital Officer. “Their technology gives us unprecedented operational visibility that has dramatically accelerated our AI transformation. We’re excited to continue working together as we scale what’s possible with AI across the business.”

“The mandate for enterprise leaders right now is to identify where AI can create measurable operational advantage. That question cannot be answered unless the organization has a clear understanding of how work really gets done, said Raman Khanna, Managing Director, Dell Technologies Capital. “Skan AI has built the observation and context layer that provides that understanding, helping enterprises deploy AI more effectively and move from experimentation to measurable impact. We’re proud to support them as they continue to define this category.”

“We invest in durable advantages, and SkanAI is building an important layer of enterprise business technology by helping organizations connect the information and context behind how work gets done,” said Kate Strubhar, a State Farm Ventures® executive. “That foundation can help businesses improve collaboration, increase productivity and helps maximize the value of technologies used every day.”

Watch the Series C announcement: skan.ai/series-c

Read more from Avinash Misra, Co-founder and CEO: skan.ai/blog

About Skan AI
Skan AI is the context graph of work for enterprise AI: a continuously evolving record of how work actually happens across every system, application, and exception. Skan observes billions of real work signals and distills them into the execution logic AI needs: the sequence, the judgment calls, and the reality logs and documents will never show.

Skan AI has cleared information security review at leading Fortune 50 banks, insurance carriers, and healthcare organizations, environments where most AI tools can’t operate. Trusted by 1/4th of the Fortune 50 and 7 of the top 10 banks, Skan AI delivers average operational savings of 30 to 40 percent and more than $500 million in cumulative customer value to date.

For more information visit www.skan.ai

SOURCE Skan AI